Literature DB >> 11976759

Effects of cytotoxic nucleus accumbens lesions on instrumental conditioning in rats.

R de Borchgrave1, J N P Rawlins, A Dickinson, B W Balleine.   

Abstract

In two experiments the involvement of the nucleus accumbens in instrumental conditioning was investigated using rats as subjects. In experiment 1, extensive bilateral cytotoxic lesions of the nucleus accumbens mildly suppressed instrumental responding reinforced with food, but had no detectable effect on the sensitivity of the rats' performance either to outcome devaluation or to degradation of the instrumental contingency. In experiment 2, restricted accumbens lesions reliably attenuated the excitatory effect of systemically administered d-amphetamine on lever pressing for a conditioned reinforcer, and completely abolished Pavlovian-instrumental transfer. Taken together these results give a picture of the involvement of the rat nucleus accumbens in instrumental conditioning. They support the widely held theory that the nucleus accumbens mediates the excitatory effects of appetitively conditioned Pavlovian signals on instrumental performance and refute the hypothesis that the nucleus accumbens is part of the neural circuitry by which incentive value is attached to the representations of instrumental outcomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976759     DOI: 10.1007/s00221-002-1031-y

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  49 in total

Review 1.  All that glitters ... dissociating attention and outcome expectancy from prediction errors signals.

Authors:  Matthew R Roesch; Donna J Calu; Guillem R Esber; Geoffrey Schoenbaum
Journal:  J Neurophysiol       Date:  2010-06-16       Impact factor: 2.714

Review 2.  Ventral striatum: a critical look at models of learning and evaluation.

Authors:  Matthijs A A van der Meer; A David Redish
Journal:  Curr Opin Neurobiol       Date:  2011-03-21       Impact factor: 6.627

3.  Facilitated extinction of appetitive instrumental conditioning following excitotoxic lesions of the core or the medial shell subregion of the nucleus accumbens in rats.

Authors:  Helen H J Pothuizen; Joram Feldon; Benjamin K Yee
Journal:  Exp Brain Res       Date:  2006-01-24       Impact factor: 1.972

Review 4.  The nucleus accumbens as part of a basal ganglia action selection circuit.

Authors:  Saleem M Nicola
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

5.  Differential involvement of the basolateral amygdala, orbitofrontal cortex, and nucleus accumbens core in the acquisition and use of reward expectancies.

Authors:  Donna R Ramirez; Lisa M Savage
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

6.  Dopamine D1 and D2 receptors in the nucleus accumbens core and shell mediate Pavlovian-instrumental transfer.

Authors:  Anja Lex; Wolfgang Hauber
Journal:  Learn Mem       Date:  2008-07-14       Impact factor: 2.460

Review 7.  How do you (estimate you will) like them apples? Integration as a defining trait of orbitofrontal function.

Authors:  Geoffrey Schoenbaum; Guillem R Esber
Journal:  Curr Opin Neurobiol       Date:  2010-03-04       Impact factor: 6.627

8.  Dorsal and ventral striatal protein synthesis inhibition affect reinforcer valuation but not the consolidation of instrumental learning.

Authors:  Sietse Jonkman; Barry J Everitt
Journal:  Learn Mem       Date:  2011-09-15       Impact factor: 2.460

Review 9.  ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Authors:  Scott H Kollins; R Alison Adcock
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-02-18       Impact factor: 5.067

Review 10.  Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action.

Authors:  Bernard W Balleine; John P O'Doherty
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.